The benefit of taxane-based therapies over fluoropyrimidine plus platinum (FP) in the treatment of esophageal cancer: a meta-analysis of clinical studies

PURPOSE: Fluoropyrimidine plus platinum (FP) is currently the standard treatment for esophageal cancer (EC). In recent years, taxane-based chemotherapy has also been used and has shown good efficacy in EC. This study aims to investigate the advantages of taxane-based over FP chemotherapy, as well as...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Tao, Yu, Jie, Liu, Min, Chen, Yanliang, Zhu, Caiyun, Lu, Lin, Wang, Mingzhu, Min, Lingfeng, Liu, Xinxin, Zhang, Xizhi, Gubat, Johannes A, Chen, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6368118/
https://www.ncbi.nlm.nih.gov/pubmed/30787595
http://dx.doi.org/10.2147/DDDT.S189514

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6368118/
https://www.ncbi.nlm.nih.gov/pubmed/30787595
http://dx.doi.org/10.2147/DDDT.S189514

Ejemplares similares